Block the great escape

Xomics is a preclinical-stage  biotech  start-up inventing novel broad-spectrum biologics for overcoming tumor escape - a critical challenge in fighting cancer.

Cancer Cell Plasticity is a fundamental non-genetic mechanism leading to tumor recurrence and deadly metastasis. Through changing their "identities",  a small number of highly plastic cancer cells can escape immune attack, survive current therapy, and spread in the body. 

Xomics is developing  first-in-class biologics to selectively attack those persistent malignant cells throughout their escaping journey, opening new possibilities for treating many types of aggressive tumors.

Please contact us for more information.